Midostaurin (PKC412): Mechanism of Action

Midostaurin (PKC412) MOA:Targeting FLT3/PI3K-AKT for Acute Myeloid Leukemia

🎯 check Midostaurin (PKC412) product page

Midostaurin (PKC412) is a potent, ATP-competitive multi-kinase (FLT3, PKC, KIT) inhibitor. It affects FLT3, PKC, and PI3K/AKT signaling pathways, by binding to the ATP-binding site of the kinase catalytic domain, inhibiting tumor cell proliferation and inducing apoptosis.

Primary Applications and Mechanism of Action